These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 6983963)
21. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA. Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806 [TBL] [Abstract][Full Text] [Related]
22. The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis. Matsumoto I; Muraki Y; Yasukochi T; Hua Z; Kori Y; Hayashi T; Goto D; Ito S; Tsutsumi A; Ikeda K; Sumichika H; Sumida T Int J Mol Med; 2005 Nov; 16(5):793-800. PubMed ID: 16211246 [TBL] [Abstract][Full Text] [Related]
23. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester. Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996 [TBL] [Abstract][Full Text] [Related]
24. Immune reactivity to native type II collagen in rheumatoid arthritis assessed by the leukocyte adherence inhibition assay and radioimmunoassay. Tannenbaum H; Clague RB; Holt PJ; Wild J Clin Invest Med; 1982; 5(4):231-5. PubMed ID: 7160110 [TBL] [Abstract][Full Text] [Related]
26. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219 [TBL] [Abstract][Full Text] [Related]
27. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [TBL] [Abstract][Full Text] [Related]
28. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester. Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254 [TBL] [Abstract][Full Text] [Related]
29. [Circulating immune complexes and anti-IgG antibodies in rheumatoid arthritis]. Duquesnoy B; Santoro F; Wattre P; Delcambre B Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):417-21. PubMed ID: 308254 [TBL] [Abstract][Full Text] [Related]
30. [Immunology of the primary inflamed joint]. Fehr K Z Gesamte Inn Med; 1987 Aug; 42(15):423-8. PubMed ID: 3314204 [TBL] [Abstract][Full Text] [Related]
31. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594 [TBL] [Abstract][Full Text] [Related]
32. Collagen antibodies and collagen- anticollagen immune complexes in rheumatoid arthritis. Steffen C; Ludwig H; Knapp W; Thumb N; Eberl R; Frank O; Freilinger H Z Rheumatol; 1975; 34(11-12):391-9. PubMed ID: 1108503 [TBL] [Abstract][Full Text] [Related]
33. Different lymphocyte populations in rheumatoid arthritis and their relationship to anti-Ig activities. Natvig JB; Froland SS; Wisloff F; Munthe E Ann Clin Res; 1975 Jun; 7(3):146-53. PubMed ID: 1081361 [TBL] [Abstract][Full Text] [Related]
34. p205 is a major target of autoreactive T cells in rheumatoid arthritis. Bläss S; Schumann F; Hain NA; Engel JM; Stuhlmüller B; Burmester GR Arthritis Rheum; 1999 May; 42(5):971-80. PubMed ID: 10323453 [TBL] [Abstract][Full Text] [Related]
35. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846 [TBL] [Abstract][Full Text] [Related]
36. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Bokarewa M; Lindblad S; Bokarew D; Tarkowski A Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483 [TBL] [Abstract][Full Text] [Related]
37. Molecular studies of rheumatoid factor using pseudobioaffinity membrane chromatography. Kamalanathan AS; Vijayalakshmi MA J Mol Recognit; 2009; 22(2):146-53. PubMed ID: 18828180 [TBL] [Abstract][Full Text] [Related]
38. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679 [TBL] [Abstract][Full Text] [Related]
39. Some humoral immunological aspects of the rheumatoid arthritis correlated with the ultrastructural changes of the rheumatoid synovial fluid. Ciobanu A; Ciobanu IR; Ioniţă A; Stoicescu M; Stroescu I; Caralicea M; Curuţ O Rom J Morphol Embryol; 1992; 38(3-4):143-54. PubMed ID: 1285262 [TBL] [Abstract][Full Text] [Related]
40. A novel monospecific IgG2/lambda-autoantibody with specificity for a mitochondrial antigen: evidence for an antigen-driven pathogenetic B-cell response in rheumatoid synovial tissue, induced by tissue alteration. Krenn V; Molitoris R; Berek C; Sack U; König A; Müller-Deubert S; Kempf V; Mosgoeller W; Kerkau T; Vollmers HP; Müller-Hermelink HK Lab Invest; 1998 Apr; 78(4):485-96. PubMed ID: 9564893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]